(IN BRIEF) AstraZeneca has announced its definitive agreement to acquire Gracell Biotechnologies Inc. (NASDAQ: GRCL), a global biopharmaceutical company specializing in cell therapies for cancer and autoimmune diseases. This strategic move aims to bolster AstraZeneca’s presence in the field of … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acquisition, Adrian Kemp, AstraZeneca, cell therapy, Dr. William Cao, Gracell Biotechnologies, Gracell's GC012F, partnership, Susan Galbraith, sustainability
(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity treatment. The collaboration will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy development … Read the full press release
(PRESSEMITTEILUNG) STOCKHOLM, 22-Jun-2022 — /EuropaWire/ — EQT AB, eine zweckorientierte globale Investmentgesellschaft, hat die Übernahme von SPT Labtech bekannt gegeben von Battery Ventures, einer globalen, technologieorientierten Investmentgesellschaft, für 650 Mio. GBP (~ 756 Mio. EUR). SPT Labtech ist ein britisches … Read the full press release
Posted in Business, Investment, Management, Science, Sweden, Technology
Tagged automated liquid handling, Battery Ventures, BCG, cell therapy, Charles Russell Speechlys, Cryo-EM, David Newble, Deloitte, EQT, EQT Private Equity, Evercore, gene therapy, J.P. Morgan, Kirkland & Ellis, life science research, Life Science Tools, liquid handling, Michael Bauer, miniaturization trends, mRNA, Ringstone, sample preparation, SecondSight Law, SPT Labtech, storage instruments, The Footprint Firm, TTP Group
(PRESS RELEASE) STOCKHOLM, 22-Jun-2022 — /EuropaWire/ — EQT AB, a purpose-driven global investment organization, has announced the acquisition of SPT Labtech from Battery Ventures, a global, technology-focused investment firm, for GBP 650 million (~ EUR 756 million). SPT Labtech is … Read the full press release
Posted in Business, Industrial, Investment, Management, News, Science, Sweden, Technology
Tagged automated liquid handling, Battery Ventures, BCG, cell therapy, Charles Russell Speechlys, Cryo-EM, David Newble, Deloitte, EQT, EQT Private Equity, Evercore, gene therapy, J.P. Morgan, Kirkland & Ellis, life science research, Life Science Tools, liquid handling, Michael Bauer, miniaturization trends, mRNA, Ringstone, sample preparation, SecondSight Law, SPT Labtech, storage instruments, The Footprint Firm, TTP Group
Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems / Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of more … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged Bayer AG, Cas enzymes, Cas14, Casɸ, cell therapy, CRISPR, Dr. Imke Meyer, Dr. Peter Nell, gene augmentation, gene editing, gene therapy, gene-editing technology, gene-editing therapies, iPSC, liver diseases, Mammoth Biosciences, Mohana Ray, pluripotent stem cell, Stefan Oelrich, vivo projects
(PRESS RELEASE) SINGAPORE, 22-Jul-2021 — /EuropaWire/ — Kuehne+Nagel, one of the world’s leading logistics companies, has announced that its subsidiary QuickSTAT has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT’s … Read the full press release
Posted in Business, Healthcare, Industrial, Infrastructure & Utilities, News, Pharma & Biotech, Switzerland, Transportation & Logistics
Tagged biologics, biomedical science hub, cell therapy, clinical research samples, clinical trial logistics, clinical trial supplies, conditioning facility, control tower, Cyril Leger, gene therapy, Healthcare, Healthcare Logistics, investigational drugs, investment, Jack Liu, Kuehne+Nagel, logistics, pharma, pharmaceutical product lifecycle, QuickSTAT, Singapore, time and temperature shipping, vaccines
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
